Have a personal or library account? Click to login
Assessing the role of serum Pentraxin-3 (PTX3) levels in hypothyroidism patients as risk marker of insulin resistance Cover

Assessing the role of serum Pentraxin-3 (PTX3) levels in hypothyroidism patients as risk marker of insulin resistance

Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 3 (September 2023)
By: Israa Jafar,  Hanaa Addai Ali,  Rawaa Adday Ali and  Mohauman Mohammed Al-Rufaie  
Open Access
|Sep 2023

Authors

Israa Jafar

Department of Chemistry, Faculty of Science, University of Kufa, Najaf, Iraq

Hanaa Addai Ali

Department of Chemistry, Faculty of Science, University of Kufa, Najaf, Iraq

Rawaa Adday Ali

Department of Microbiology, College of Veterinary Medicine, Al-Qasim Green University, Babylon, Iraq

Mohauman Mohammed Al-Rufaie

muhaimin.alrufaie@uokufa.edu.iq

Department of Chemistry, Faculty of Science, University of Kufa, Najaf, Iraq
DOI: https://doi.org/10.2478/cipms-2023-0030 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 174 - 179
Submitted on: May 26, 2023
|
Accepted on: Jun 15, 2023
|
Published on: Sep 28, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
serum PTX3 levels,
hypothyroidism,
subclinical hypothyroidism,
thyroid hormone levels and TSH levels
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2023 Israa Jafar, Hanaa Addai Ali, Rawaa Adday Ali, Mohauman Mohammed Al-Rufaie, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 36 (2023): Issue 3 (September 2023)Next article